elianagrace26
| Zuletzt Online: 15.04.2022
Name
Eliana Grace
E-Mail:
elianagrace226@gmail.com
Registriert am:
15.04.2022
Beschreibung
The Indian biosimilar market is expected to reach $35.7 billion by 2025, up from $11.8 billion in 2020, at a CAGR of 24.7 percent. India’s biologics market will grow at a compound annual growth rate (CAGR) of 22 percent to hit $12 billion by 2025.The market currently is dominated by simple biologics, such as therapies for the treatment of diabetes (insulin), oncology (EPO and mAbs), autoimmune, and cardiovascular diseases. Similar biologics for insulin and EPO enjoy 80 to 85 percent market share in India.
Geschlecht
weiblich
Dieses Mitglied war noch nicht im Forum aktiv.
|
Forum Software ©Xobor.de | Forum erstellen |